CIK 0001674930
- Accelerated filer
Fulgent Genetics, Inc.
Sign in to watch- Ticker
- FLGT
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812621304
- Phone
- +1 626-350-0537
- Business address
- 4399 SANTA ANITA AVE, EL MONTE, CA, 91731
- Former names
- Fulgent Diagnostics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $117,132
- in 4 filings
Net −$117,132. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-10 | KIM PAUL CFO and Treasurer | Sale | −16,958 | $51.94 | $881K | 174,563 |
| 2020-12-09 | KIM PAUL CFO and Treasurer | Sale | −10,662 | $51.60 | $550K | 191,521 |
| 2020-12-02 | KIM PAUL CFO and Treasurer | Sale | −630 | $45.09 | $28K | 231,502 |
| 2020-12-02 | KIM PAUL CFO and Treasurer | Sale | −29,319 | $46.62 | $1.4M | 202,183 |
| 2020-12-02 | Xie Jian Chief Operating Officer | Sale | −1,000 | $46.00 | $46K | 431,689 |
| 2020-12-01 | Xie Jian Chief Operating Officer | Sale | −1,000 | $45.16 | $45K | 432,689 |
| 2020-11-30 | Xie Jian Chief Operating Officer | Sale | −3,000 | $43.17 | $130K | 434,085 |
| 2020-11-30 | Xie Jian Chief Operating Officer | Sale | −396 | $43.59 | $17K | 433,689 |
| 2020-11-23 | Xie Jian Chief Operating Officer | Sale | −6,000 | $44.08 | $264K | 437,085 |
| 2020-11-20 | Xie Jian Chief Operating Officer | Sale | −1,000 | $42.50 | $43K | 443,085 |
| 2020-11-18 | Xie Jian Chief Operating Officer | Sale | −3,000 | $44.83 | $134K | 444,085 |
| 2020-11-17 | Xie Jian Chief Operating Officer | Sale | −3,206 | $45.45 | $146K | 447,585 |
| 2020-11-17 | Xie Jian Chief Operating Officer | Sale | −500 | $44.61 | $22K | 447,085 |
| 2020-11-17 | KIM PAUL CFO and Treasurer | Sale | −441 | $45.45 | $20K | 235,458 |
| 2020-11-17 | KIM PAUL CFO and Treasurer | Sale | −3,326 | $45.45 | $151K | 232,132 |
| 2020-11-17 | Gao Hanlin Chief Scientific Officer | Sale | −301 | $45.45 | $14K | 813,391 |
| 2020-11-17 | BOLGER JOHN C Director | Exercise or conversion | +2,631 | $0.38 | $1,000 | 4,644 |
| 2020-11-17 | BOLGER JOHN C Director | Sale | −4,269 | $44.24 | $189K | 375 |
| 2020-11-17 | BOLGER JOHN C Director | Exercise or conversion · Stock Options (Right to Buy) | −2,631 | 0 | ||
| 2020-11-16 | KIM PAUL CFO and Treasurer | Sale | −100,000 | $46.17 | $4.6M | 235,899 |
Page 25 of 31 · 601 trades